Risk of Myopathy Associated With DPP-4 Inhibitors in Combination With Statins: A Disproportionality Analysis Using Data From the WHO and French Spontaneous Reporting Databases

Diabetes Care - United States
doi 10.2337/dc16-1822
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Risk of Amputations Associated With SGLT2 Inhibitors Compared to DPP-4 Inhibitors: A Propensity-Matched Cohort Study

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Combination Therapy With DPP-4 Inhibitors and Pioglitazone in Type 2 Diabetes: Theoretical Consideration and Therapeutic Potential

Vascular Health and Risk Management
2008English

Safety of Oral Nifuroxazide – Analysis of Data From a Spontaneous Reporting System

Acta Poloniae Pharmaceutica
PharmacologyPharmaceutical Science
2019English

Erratum To: DPP-4 Inhibitors in Diabetic Complications: Role of DPP-4 Beyond Glucose Control

Archives of Pharmacal Research
Organic ChemistryDrug DiscoveryMolecular Medicine
2016English

Statins Are Associated With a Lower Risk of Death in People With Heart Failure

BMJ
2006English

Managing Diabetic Patients With Moderate or Severe Renal Impairment Using DPP-4 Inhibitors: Focus on Vildagliptin

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2013English

PND9 the Role of Spontaneous Events Databases for Benefit-Risk Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Statins Are Associated With Reduced Risk of Esophageal Cancer, Particularly in Patients With Barrett's Esophagus: A Systematic Review and Meta-Analysis

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2013English

Reporting a Rare Form of Myopathy, Myopathy With Extrapyramidal Signs, in an Iranian Family Using Next Generation Sequencing: A Case Report

BMC Medical Genetics
Genetics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy